Trial
NCT03463161
Epacadostat and Pembrolizumab in Patients With Head and Neck Cancer That Have Failed Prior Immunotherapy
Phase IITERMINATEDOTHER/UNKNOWNConfidence: LOW
Sponsor
University of Chicago
Collaborators
—
Condition
Head and Neck Squamous Cell Carcinoma
Intervention
Pembrolizumab
Why stopped
Study stopped early due to investigator conflict of interest.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2020-01-27